An electrochemical DNA hybridization detection assay based on a silver nanoparticle label

A novel, sensitive electrochemical DNA hybridization detection assay, using silver nanoparticles as the oligonucleotide labeling tag, is described. The assay relies on the hybridization of the target DNA with the silver nanoparticle-oligonucleotide DNA probe, followed by the release of the silver metal atoms anchored on the hybrids by oxidative metal dissolution and the indirect determination of the solubilized Ag(I) ions by anodic stripping voltammetry (ASV) at a carbon fiber ultramicroelectrode. The influence of the relevant experimental variables, including the surface coverage of the target oligonucleotide, the duration of the silver dissolution steps and the parameters of the electrochemical stripping measurement of the silver(I) ions, is examined and optimized. The combination of the remarkable sensitivity of the stripping metal analysis at the microelectrode with the large number of silver(I) ions released from each DNA hybrid allows detection at levels as low as 0.5 pmol L(-1) of the target oligonucleotides.     

Synthesis, reaction and structure of a series of chromium(III) complexes containing oxalate ligand

A series of chromium(III) complexes [Cr(bipy)(HC₂O₄)₂]Cl·3H₂O (1), [Cr(phen)(HC₂O₄)₂]Cl·3H₂O (2), [Cr(phen)₂(C₂O₄)]ClO₄ (3), [Cr₂(bipy)₄(C₂O₄)](SO₄)·(bipy)_0.5·H₂O (4) and [Mn(phen)₂(H₂O)₂]₂[Cr(phen)(C₂O₄)₂]₃ClO₄·14H₂O (5) were synthesized (bipy=4,4′-bipyridine, phen=1,10-phenanthroline), while the crystal structures of 1 and 3–5 have been determined by X-ray analysis. 1 and 3 are mononuclear complexes, 4 contains binuclear chromium(III) ions and 5 is a 3D supromolecule formed by complicated hydrogen bonding. 1–3 are potential molecular bricks of chromium(III) building blocks for synthesis heterometallic complexes. When we use these molecular bricks as ligands to react with other metal salts, unexpected complexes 4 and 5 are isolated in water solution. The synthesis conditions and reaction results are also discussed.     

Controlled morphology synthesis of β-FeOOH and the phase transition to Fe2O3

The hexagram and arrayed β-FeOOH nanorods were first synthesized free of surfactants through the solvent-thermal method. X-ray powder diffraction (XRD), transmission electron microscopy (TEM), selected area electron diffraction (SAED), field emission scanning electron microscopy (FESEM), energy dispersive X-ray spectrum (EDAX) and thermal gravimetric analysis (TGA) were used to characterize the as-prepared products. The TEM and FESEM images showed that hexagram β-FeOOH and arrayed rod-like β-FeOOH with an average diameter of 10-15 nm and an average length of 100 nm (aspect ratio is about 10) were prepared. Electrochemical tests show that these nanorods deliver a large discharge capacity of 277 mA h g⁻¹ versus Li metal at 0.1 mA cm⁻² (voltage at 1.5-4.2 V). Treated the as-synthesized rod-like β-FeOOH by annealing, rhombus hematite was obtained.     

Sequential C–O decarboxylative vinylation/C–H arylation of cyclic oxalates via a nickel-catalyzed multicomponent radical cascade

A selective, sequential C–O decarboxylative vinylation/C–H arylation of cyclic alcohol derivatives enabled by visible-light photoredox/nickel dual catalysis is described. This protocol utilizes a multicomponent radical cascade process, i.e. decarboxylative vinylation/1,5-HAT/aryl cross-coupling, to achieve efficient, site-selective dual-functionalization of saturated cyclic hydrocarbons in one single operation. This synergistic protocol provides straightforward access to sp³-enriched scaffolds and an alternative retrosynthetic disconnection to diversely functionalized saturated ring systems from the simple starting materials.

A selective, sequential C–O decarboxylative vinylation/C–H arylation of cyclic alcohol derivatives enabled by visible-light photoredox/nickel dual catalysis has been described.     

交联1,4—顺式聚丁二烯的取向结晶

用ＷＡＸＤ和ＳＡＸＳ研究交联１，４－顺式聚丁二烯的取向结晶。结果表明：该试样在拉伸状态时，形成折叠链片晶，而不是伸直链纤维晶。片晶之间断产生新的片晶，使长周期减小，并且片晶的横向尺寸不断增大，由此导致结晶度增大。     

丙酮酸·邻菲咯啉·稀土三元固体配合物的合成和表征

丙酮酸在生物体内具有生理功能,它与稀土的二元配合物巳有报导。近期的研究结果表明某些稀土的邻菲咯啉三元配合物有一定的抑菌能力。本文报道丙酮酸(pyr-H)、邻菲咯啉(phen)稀土三元固体配合物的合成与表征结果。 按硝酸稀土:邻菲咯啉:丙酮酸(摩尔比)=1:1:3,将一定量的硝酸稀土加入无水乙醇中,溶解完全后,加入计算量丙酮酸,加热搅拌半小时,然后慢慢加入含计算量邻菲咯啉的     

Synthesis and characterization of an open framework ballium selenide: Ga4Se7(en)2 x (enH)2

An open framework gallium selenide, Ga(4)Se(7)(en)(2).(enH)(2), has been prepared by the direct reaction of gallium (Ga) and selenium (Se) in ethylenediamine (en), in which both covalent and hydrogen bonds have been employed to combine the inorganic structures and organic spacers to build layers with micropores. Its structure has been determined by X-ray diffraction. Its thermal and optical properties have been characterized by TGA and UV-vis, Raman, and IR spectroscopies, respectively.     

铂电极上异黄樟油和胡椒醛电氧化的SERS研究

采用循环伏安(CV)法和原位表面增强拉曼光谱(SERS)技术, 研究了非水体系中反应物异黄樟油和目标产物胡椒醛在粗糙铂电极上的电氧化行为, 发现胡椒醛在电位≥1.50 V时将进一步氧化, 而且从分子水平证实, 在胡椒醛的氧化电位(≥1.50 V) 下, 波长为632.8 nm的激光对胡椒醛的氧化有助催化作用. 由异黄樟油直接电氧化合成胡椒醛的电位(E)应控制在1.20 V相似文献   

Prediction of retention indexes. III. Silylated derivatives of polar compounds.

Polar compounds containing hydroxyl, amino and carboxyl groups, singly or in combination, can be chromatographed after the polar functional groups are silylated. The silylated derivatives of acids, alcohols, amines, diols, amino alcohols, amino acids are shown to behave chromatographically as hydrocarbons, and their retention indexes can be readily predicted from their base values. The column difference, namely, the difference between the retention indexes of the analyte on polar and non-polar columns is minimal for the silylated derivatives in comparison to that observed for the underivatized analytes. This minimal column difference is attributed to the hydrocarbon-like chromatographic characteristics of the silylated derivatives. The retention indexes of the silyl derivatives appear to correlate with the atom number Z of the analyte.     

Mass spectrometry-based chemical mapping and profiling toward molecular understanding of diseases in precision medicine

Precision medicine has been strongly promoted in recent years. It is used in clinical management for classifying diseases at the molecular level and for selecting the most appropriate drugs or treatments to maximize efficacy and minimize adverse effects. In precision medicine, an in-depth molecular understanding of diseases is of great importance. Therefore, in the last few years, much attention has been given to translating data generated at the molecular level into clinically relevant information. However, current developments in this field lack orderly implementation. For example, high-quality chemical research is not well integrated into clinical practice, especially in the early phase, leading to a lack of understanding in the clinic of the chemistry underlying diseases. In recent years, mass spectrometry (MS) has enabled significant innovations and advances in chemical research. As reported, this technique has shown promise in chemical mapping and profiling for answering “what”, “where”, “how many” and “whose” chemicals underlie the clinical phenotypes, which are assessed by biochemical profiling, MS imaging, molecular targeting and probing, biomarker grading disease classification, etc. These features can potentially enhance the precision of disease diagnosis, monitoring and treatment and thus further transform medicine. For instance, comprehensive MS-based biochemical profiling of ovarian tumors was performed, and the results revealed a number of molecular insights into the pathways and processes that drive ovarian cancer biology and the ways that these pathways are altered in correspondence with clinical phenotypes. Another study demonstrated that quantitative biomarker mapping can be predictive of responses to immunotherapy and of survival in the supposedly homogeneous group of breast cancer patients, allowing for stratification of patients. In this context, our article attempts to provide an overview of MS-based chemical mapping and profiling, and a perspective on their clinical utility to improve the molecular understanding of diseases for advancing precision medicine.

An overview of MS-based chemical mapping and profiling, indicating its contributions to the molecular understanding of diseases in precision medicine by answering "what", "where", "how many" and "whose” chemicals underlying clinical phenotypes.